Pandora announces the launch of the Launchpad platform

According to the settlement agreement, Genevant Sciences, a subsidiary of Roivant Sciences Ltd., will grant Moderna, Inc. a non-exclusive license allowing the use of its lipid nanoparticle delivery technology for applications in the field of infectious diseases.

According to the latest filing submitted to the U.S. Securities and Exchange Commission, The Walt Disney Company's 364-day credit arrangement will expire on February 26, 2027.

Orion Marine Group recently released its 2026 financial guidance, which fully demonstrates the strong appeal of its end markets and its solid strategic positioning.

According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), Mira Pharma (stock code: MIRA) announced that its candidate drug Ketamir-2 did not observe clinically significant dissociative or psychosis-inducing side effects in Phase I clinical trials.